Vaxart Inc (VXRT)
$5.00 0.44 (8.09%)
19:59 EDT VXRT Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 35.71M
PE Ratio -0.91
Volume (Avg. Vol.) 5.28M
Day's Range 4.93 - 5.29
52-Week Range 0.27 - 17.49
Dividend & Yield N/A (N/A)
VXRT Stock Predictions, Articles, and Vaxart Inc News
- From InvestorPlace
- From the Web
Vaxart (VXRT) news for Monday isn't good as the company faces a federal investigation and lawsuits over its coronavirus claims.
Louis Navellier zeroes in on eventual stock winners, spots their key momentum levers, and allows smart folks to learn how to get positioned months or even years before the mainstream media finally catches on.
The market is sliding on today on Trump coronavirus news following confirmation that President Donald Trump tested positive.
Vaxart just announced it will begin enrolling participants in human trials of its coronavirus vaccine. VXRT stock is popping in response.
By Ian Cooper
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
Unlike the broader market, these stocks to buy have managed to hold up strong amid the ongoing public health crisis.
VXRT soared last week on favorable data. The company is developing a vaccine for the flu. And while the vaccine could be a game changer, VXRT stock still poses notable risks.
Navellier RatingsPowered by Portfolio Grader